HealthSouth (HLS) Guides FY15 adj.-EPS Above Views; Offers FY16 Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/26/2026
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Stock action shows confidence in central banks: BofA’s Hartnett
- Oil prices slide about 2% as US, Iran explore path out of war
- Why stocks held up despite rising yields and $100 oil? These 2 words explain it
- Barclays asks if equity markets are nearing the boiling point
- White House blocks CNN from Air Force One trip, Washington Post reports
- Exclusive-SK Hynix's Solidigm weighs IPO that could value the unit at up to $150 billion, sources say
- Merck and Daiichi Sankyo withdraw lung cancer drug application
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Fox Factory sells Marucci Sports for $225M, cuts debt
HealthSouth's (HLS) Non-Aggressive 2016 Outlook is as Expected - Mizuho Securities Reiterates Buy
January 11, 2016 10:05 AM ESTMizuho Securities reiterated a Buy rating and $40.00 price target on HealthSouth (NYSE: HLS) after the company reiterated its 2015, and gave a first look at 2016. For 2015, HLS reiterated a range of $675mm-$685mm vs. consensus of $677mm. GAAP EPS also looks to be likely above... More
